US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Adlai Nortye Ltd.

0.1835

0.0000

Volume:- -

Turnover:- -

Market Cap:12.58M

PE:1.53

High:0.1835

Open:0.1835

Low:0.1835

Close:0.1835

52wk High:0.1835

52wk Low:0.1835

Shares:68.57M

Float Shares:3.00M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.1200

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Adlai Nortye Ltd. Sponsored ADR (ANL) Receives a Buy from Cantor Fitzgerald

Adlai Nortye: Buy Rating Reaffirmed as Dual-Arm AN9025 Strategy Advances; $20 Price Target Maintained

Adlai Nortye Doses First US Patient in Weekly Arm of Phase 1 AN9025 Trial

MT Newswires Live

Adlai Nortye doses first patient in AN9025 trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ALN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALN\",,,,,undefined,":{"symbol":"ALN","market":"US","secType":"STK","nameCN":"Adlai Nortye Ltd.","latestPrice":0.1835,"timestamp":1784664000000,"preClose":0.1835,"halted":9,"volume":0,"delay":0,"changeRate":0,"floatShares":3000000,"shares":68570000,"eps":0.12,"marketStatus":"Post-Mkt","change":0,"latestTime":"07-21 18:44:53 EDT","open":0.1835,"high":0.1835,"low":0.1835,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.12,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1784678400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1692331200000,"exchange":"NASDAQ","adjPreClose":0.1835,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALN\",,,,,undefined,":{"symbol":"ALN","floatShares":3000000,"roa":"--","roe":"--","lyrEps":0,"shares":68570000,"dividePrice":0,"high":0.1835,"amplitude":0,"preClose":0.1835,"low":0.1835,"week52Low":0.1835,"pbRate":"--","week52High":0.1835,"institutionHeld":0,"latestPrice":0.1835,"eps":0.12,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.12,"open":0.1835},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652918902","title":"Adlai Nortye Ltd. Sponsored ADR (ANL) Receives a Buy from Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2652918902","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652918902?lang=en_us&edition=fundamental","pubTime":"2026-07-20 17:06","pubTimestamp":1784538376,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Li Watsek maintained a Buy rating on Adlai Nortye Ltd. Sponsored ADR on July 16. The company’s shares closed last Friday ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/adlai-nortye-ltd-sponsored-adr-anl-receives-a-buy-from-cantor-fitzgerald-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/adlai-nortye-ltd-sponsored-adr-anl-receives-a-buy-from-cantor-fitzgerald-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APIE","ALN","AADR","LU2133065610.SGD","DINT","BK4139","CVY","DIVL","SAPH","ANL","IE00BZ199S13.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652266114","title":"Adlai Nortye: Buy Rating Reaffirmed as Dual-Arm AN9025 Strategy Advances; $20 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2652266114","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652266114?lang=en_us&edition=fundamental","pubTime":"2026-07-17 00:45","pubTimestamp":1784220325,"startTime":"0","endTime":"0","summary":"In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Adlai Nortye Ltd. Sponsored ADR, with a price target o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/adlai-nortye-buy-rating-reaffirmed-as-dual-arm-an9025-strategy-advances-20-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/adlai-nortye-buy-rating-reaffirmed-as-dual-arm-an9025-strategy-advances-20-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651449998","title":"Adlai Nortye Doses First US Patient in Weekly Arm of Phase 1 AN9025 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2651449998","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651449998?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:37","pubTimestamp":1784201836,"startTime":"0","endTime":"0","summary":"Adlai Nortye  said Thursday it has dosed the first patient in the US in the intermittent weekly dosing arm of its phase 1 trial evaluating AN9025 in patients with advanced or metastatic solid tumors harboring RAS mutations.The company said that intermittent dosing offers a differentiated approach and may widen the therapeutic window based on preclinical data.Adlai said it plans to share initial phase 1 dose escalation data in the first half of next year from the continuous once-daily arm of the study, with a potential early look at the once-weekly arm.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ALN","BK7104","LU2133065610.SGD","ANL","IE00BZ199S13.USD","ANL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651446711","title":"Adlai Nortye doses first patient in AN9025 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2651446711","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651446711?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:10","pubTimestamp":1784200225,"startTime":"0","endTime":"0","summary":"Adlai Nortye (ANL) announced that the first patient has been dosed in the United States in the intermittent weekly dosing arm of the ongoing Phase ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adlai-nortye-doses-first-patient-in-an9025-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adlai-nortye-doses-first-patient-in-an9025-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ199S13.USD","BK4139","LU2133065610.SGD","ANL","ALN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ALN\",params:#limit:6,delay:false,,,undefined,":[]}}